Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP406171.RA_cegZle8qPTyv8orOGRDvO6esBQPG7mx2mLf6FLaBAo130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP406171.RA_cegZle8qPTyv8orOGRDvO6esBQPG7mx2mLf6FLaBAo130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP406171.RA_cegZle8qPTyv8orOGRDvO6esBQPG7mx2mLf6FLaBAo130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP406171.RA_cegZle8qPTyv8orOGRDvO6esBQPG7mx2mLf6FLaBAo130_provenance.
- NP406171.RA_cegZle8qPTyv8orOGRDvO6esBQPG7mx2mLf6FLaBAo130_assertion description "[Collectively, these findings show that GBM therapeutic resistance to EGFR inhibitors may be explained by compensatory activation of EGFR-related family members (ERBB2, ERBB3) enabling GBM CSC proliferation, and therefore simultaneous blockade of multiple ERBB family members may be required for more efficacious GBM therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP406171.RA_cegZle8qPTyv8orOGRDvO6esBQPG7mx2mLf6FLaBAo130_provenance.
- NP406171.RA_cegZle8qPTyv8orOGRDvO6esBQPG7mx2mLf6FLaBAo130_assertion evidence source_evidence_literature NP406171.RA_cegZle8qPTyv8orOGRDvO6esBQPG7mx2mLf6FLaBAo130_provenance.
- NP406171.RA_cegZle8qPTyv8orOGRDvO6esBQPG7mx2mLf6FLaBAo130_assertion SIO_000772 22745588 NP406171.RA_cegZle8qPTyv8orOGRDvO6esBQPG7mx2mLf6FLaBAo130_provenance.
- NP406171.RA_cegZle8qPTyv8orOGRDvO6esBQPG7mx2mLf6FLaBAo130_assertion wasDerivedFrom befree-20140225 NP406171.RA_cegZle8qPTyv8orOGRDvO6esBQPG7mx2mLf6FLaBAo130_provenance.
- NP406171.RA_cegZle8qPTyv8orOGRDvO6esBQPG7mx2mLf6FLaBAo130_assertion wasGeneratedBy ECO_0000203 NP406171.RA_cegZle8qPTyv8orOGRDvO6esBQPG7mx2mLf6FLaBAo130_provenance.
- befree-20140225 importedOn "2014-02-25" NP406171.RA_cegZle8qPTyv8orOGRDvO6esBQPG7mx2mLf6FLaBAo130_provenance.